1. |
Kamb A, Gruis NA, Weaver FT, et al. A cell cycle regulator potentially in genesis of many tumor types 〔J〕. Science, 1994; 264(2)∶436.
|
2. |
Kyomoto R, Kumazwa H, Toda Y, et al. CyclinD1gene amplification is a more potent prognostic factor than its protein overexpression in human headandneck squamouscell carcinoma 〔J〕. Int J Cancer, 1997; 74(2)∶576.
|
3. |
Bartkova J, Lukas J, Müller H, et al. CyclinD1 protein expression and function in human breast cancer 〔J〕. Int J Cancer, 1994; 57(1)∶353.
|
4. |
Michalides R, Hageman P, Tinteren H, et al. A clinicopathological study on overexpression of CyclinD1 and of p53 in a series of 248 patients with operable breast cancer 〔J〕. Br J Cancer, 1996; 73(2)∶728.
|
5. |
Paul J, Michalides R, Jannink I, et al. CyclinD1 expression in invasive breast cancer 〔J〕. Am J Pathology, 1997; 150(2)∶705.
|
6. |
Zhang SY, Caamano J, Cooper F, et al. Immunohistochemistry of CyclinD1 in human breast cancer 〔J〕. Am J Clin Pathol, 1994; 102(2)∶695.
|
7. |
沈凱, 唐孝達, 楊宇如. D類細胞周期素與癌基因和抑癌基因 〔J〕. 中華醫學遺傳學雜志, 1996; 13(6)∶361.
|
8. |
Surmacz E, Reiss K, Sell C, et al. CyclinD1 messenger RNA is inducible by plateletderived growth factor in culture fibroblasts 〔J〕. Cancer Res, 1992; 52(19)∶4522.
|
9. |
Furlanetto RW, Harwell SE, Firck KK. Insulinlike growth factor1 induces CyclinD1 expression in MG 63 human osteosarcoma cell in vitro 〔J〕. Mol Endocrinol, 1994; 8(2)∶510.
|
10. |
Surmacz E, Marina A, Mary K, et al. Type I insulinlike growth factor receptor function in breast cancer 〔J〕. Breast Cancer Research and Treatment, 1998; 47(1)∶255.
|